Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …

Results When three tests were used to define successful ablation, in group L, 32 out of 53
(60%) and 43 out of 53 (81%) patients were successfully treated versus 35 out of 55 (64%) …

Background Radioactive iodine is commonly administered following thyroidectomy for
differentiated thyroid carcinoma to ablate the thyroid remnant. The optimal administered …

PURPOSE: The optimal dose of I131 for ablation of functioning residual thyroid tissue after
surgery is controversial. The current study was conducted to determine the optimal dose of …

Objective To assess efficiency of various I-131 activities on thyroid remnant ablation in
thyroid cancer patients. The significance of patients' characteristics, pathologic features and …

Context: Radioiodine ablation of the thyroid remnant after thyroidectomy is commonly
performed in the management of patients with differentiated thyroid cancer. Although many …

Management recommendations for differentiated thyroid cancer are evolving. Total
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …

Postoperative ablation of functioning thyroid tissue has become established in the
management of differentiated thyroid cancer as the long-term risk of recurrence and death is …

Background Most patients with differentiated thyroid cancer are treated with radioiodine (131-
I) after thyroidectomy. The characteristics predictive of successful remnant ablation with low …

Background The aim of this study is to compare the effectiveness of 131 I therapy between
three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation …